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Implications   
Practice: Sixteen behavior change techniques have been identified, that may be used 
as the basis for behavior change and quality improvement interventions by clinicians 
targeting inappropriate antipsychotic prescribing to nursing home residents with 
dementia.  
  
Policy: Policymakers should consider developing suitable systems to enable 
prescribers to compare their own antipsychotic prescribing practices, to that of 
their peers, in a meaningful manner.  
  
Research: The systematic and detailed approach undertaken to identify appropriate 
BCTs in this study, could be used as an example for other interventions.   
2  
  
1 Identifying  behavior change techniques for  
2 inclusion in a complex intervention targeting  
3 antipsychotic  prescribing  to  nursing 
 home   residents with dementia.  
 5  Abstract  
6 Background:   
7 Nursing home residents with dementia are commonly prescribed antipsychotics despite the  
8 associated increased risk of harms. Interventions to optimize prescribing practice have been  
9 found to be effective in the short-term, but there is a lack of evidence to support sustainability  
10 of effects, along with a lack of theory, public involvement and transparency in the 11 
intervention development process.   
12 Purpose:  
13 Using theory has been advocated as a means of improving intervention sustainability. The 
aim  
14 of this study was therefore to identify behavior change techniques (BCTs) for inclusion in a 
complex intervention targeting antipsychotic prescribing to nursing home residents with 
 dementia.  
 17  Methods:  
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A comprehensive approach to identifying a long list of all potential BCTs from three different 18 
sources was undertaken. The most appropriate BCTs were then selected through a two-round 19 
Delphi consensus survey with a broad range of experts (n=18 panellists). Advisory groups of 20 
people with dementia, family carers, and professional stakeholders provided feedback on the 21 
final BCTs included.  22 
Results:  23 
After two Delphi survey rounds, agreement was reached on 22 BCTs. Further refinement of 24 
the selected BCTs based on advisory group and panellists’ feedback, along with use of the 25 
APEASE criteria (Affordability, Practicability, Effectiveness, Acceptability, Side effects/safety 26 
and Equity) resulted in a final list of 16 BCTs.  27 
Conclusion:  28 
The next step in intervention development will be to identify the most appropriate mode of 29 
delivery of the 16 BCTs identified for inclusion.  The study provides a case-example of a 30 
systematic approach to incorporating evidence with stakeholder views in the identification of 31 
appropriate BCTs.  32 
  33 
  34 
  35 
  36 
  37 
  38 
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Introduction  39 
Antipsychotics are commonly prescribed to nursing home residents with dementia for the 40 
management of behavioral and psychological symptoms of dementia (BPSD) [1-4]. However, 41 
antipsychotics have limited effectiveness for treating BPSD and are associated with an 42 
increased risk of mortality, stroke and other serious side effects [5, 6]. Non-pharmacologic 43 
interventions are recommended as the first line treatment for BPSD, with antipsychotics only 44 
recommended for severe symptoms, where there is significant patient distress or risk of harm, 45 
or when non-pharmacologic interventions have failed [7-9].    46 
A 2014 systematic review determined that many types of interventions were effective at 47 
reducing inappropriate antipsychotic prescribing to nursing home residents with dementia in 48 
the short-term [10]. These interventions were categorized as educational programs (n=11 49 
studies), outreach services, where specialists visited the nursing homes (n=2 studies), 50 
medication reviews (n=4 studies) and multicomponent interventions (n=5 studies) [10]. 51 
However, the review authors noted that there was a lack of evidence to support sustainability 52 
of effects. In addition, we identified a distinct lack of theory, patient and public involvement 53 
(PPI) and transparency in the intervention development processes in the included studies  54 
[10].   55 
It has been argued that interventions aimed at changing healthcare professional behaviors 56 
may not have had the desired long-term effects due to the lack of theory in the development 57 
of the intervention [11]. Evidence suggests that interventions that make extensive use of 58 
theory may have larger effects on behavior than those that use less or no theory [12]. The 59 
explicit use of theory can help us to better understand the key elements of the intervention, 60 
the participants and the context. Moreover, it can provide a generalizable framework, inform 61 
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the development, delivery and evaluation processes, and permit an exploration of potential 62 
causal mechanisms [13].  63 
There is an increasing evidence base to suggest that PPI and the incorporation of stakeholder 64 
views can enhance the quality and appropriateness of research [14]. Furthermore, from an 65 
ethical perspective, involving those who might potentially be affected by the findings in 66 
research has been strongly advocated [15].   67 
In terms of research transparency, there has been a concerted effort in recent times to 68 
improve the reliability, utility and impact of health research, while reducing research waste, 69 
through more transparent and accurate reporting [16]. Inadequate reporting of interventions 70 
may have serious consequences for clinical practice, research replication, policy making and 71 
patients, if readers cannot determine how an intervention was developed and implemented 72 
[17].  73 
Taken together, these research issues suggest the need for a systematic, transparent 74 
approach, incorporating PPI and stakeholder input in the intervention development process. 75 
The Behavior Change Wheel (BCW) is one systematic approach for applying behavioral theory 76 
to complex intervention development [18]. The BCW guidance on developing behavior change 77 
interventions was developed by synthesizing existing frameworks for intervention 78 
development according to three criteria: comprehensiveness, coherence, and a clear link to 79 
an overarching model of behavior (Figure 1).   80 
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Figure 1: The behavior change wheel [19]  81 
  82 
Essentially the BCW provides the intervention designer with theory-informed tools and 83 
techniques to help understand and change behavior in a step-by-step and transparent manner 84 
[18].  There are three main stages to the BCW. The first stage involves understanding the 85 
behavior through the conduct of a thorough analysis of the behavior and the context in which 86 
it occurs. Once a target behavior has been identified, the BCW provides guidance on 87 
identifying what needs to shift to bring about change (i.e. a ‘behavioral diagnosis’ is 88 
conducted) and mapping these determinants to intervention functions, the broad categories 89 
of ways an intervention can change behavior, and policy options. The final stage involves 90 
identifying content and implementation options. A core component of the final stage is to 91 
identify the most appropriate behavior change techniques (BCTs) for the planned intervention. 92 
BCTs are defined as the active component of an intervention designed to change behavior, 93 
and are essential for intervention transparency and future replication of interventions [20]. A 94 
comprehensive list of 93 BCTs and associated definitions exists as a standardized language 95 
known as the BCT Taxonomy version 1 (BCTTv1) [20]. By providing a standardized language to 96 
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describe intervention content, BCTs facilitate the translation of interventions into practice at 97 
scale.  98 
Identifying appropriate BCTs requires the incorporation of an understanding of influences on 99 
behavior and existing literature, with the views of key stakeholders, to ensure the intervention 100 
is context-appropriate, evidence-based, and can be translated into practice. Various methods 101 
to identify the most appropriate BCTs have been described [21]. Although there is currently 102 
no clear guidance on the optimal method, using expert consensus groups (such as Delphi 103 
surveys) and/or guidance materials matching BCTs to behavioral determinants feature 104 
prominently throughout the literature [22-26].    105 
A Delphi survey is  defined as a “group facilitation technique that seeks to obtain consensus 106 
on the opinions of experts through a series of structured questionnaires (or rounds)” [27].   107 
Previous studies have used Delphi surveys to achieve consensus from stakeholders,  on which  108 
BCTs are potentially suitable for inclusion in behavior change interventions [26, 28, 29]. 109 
However, the approaches used differed significantly across studies, even for the same 110 
behavior. For example, with regards to smoking behaviors, one study retrieved 55 BCTs linked 111 
to the determinants of waterpipe smoking from the literature, divided these 55 BCTs into 112 
three broad intervention groups, and then 14 panellists ranked each BCT in order of perceived 113 
importance, within each of the three intervention groups [28]. Another study took a very 114 
different approach at identifying suitable BCTs for inclusion in an intervention to reduce 115 
smoking during pregnancy, through a three-round Delphi survey with 44 panellists [29]. 116 
Round-one asked panellists to rate the ‘influence’ and ‘difficulty’ of 34 pre-identified barriers 117 
and facilitators using a 5-point Likert scale, and gathered panellists' suggestions on ways to 118 
address these. Rounds two and three sought further consensus on the barriers and facilitators 119 
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and on ‘appropriateness’ of the panellists’ suggestions. The suggestions were then coded for 120 
BCTs by the research team after the Delphi study was completed [29]. Hence even within 121 
similar behavior change contexts, there are significant differences in the approaches 122 
undertaken to identify BCTs. Therefore, there is a need to better standardize, and report, the 123 
approach to BCT identification so that future researchers can replicate and improve upon this 124 
process.  125 
The aim of this study was to identify BCTs for inclusion in a complex intervention targeting 126 
antipsychotic prescribing behaviors (appropriate requesting by nurses and prescribing by 127 
general practitioners [GPs]). The study is part of a larger project which aims to develop an 128 
evidence-based, theoretically informed complex intervention to sustainably improve the 129 
appropriateness of antipsychotic prescribing to nursing home residents with dementia, using 130 
the BCW approach, with stakeholder engagement, and PPI throughout. The study also 131 
provides a case-example of a systematic approach to incorporating evidence with stakeholder 132 
views in the identification of appropriate BCTs which may be of use to the development of 133 
interventions across behaviors and contexts.  134 
Methods  135 
The current study focused on the process of identifying BCTs for inclusion in a complex 136 
intervention targeting appropriate requesting and prescribing of antipsychotics to nursing 137 
home residents with dementia, in Ireland (Figure 2). To provide context for this process, an 138 
overview of the development of this complex intervention is described, followed by the 139 
detailed methods of the current study.   140 
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Figure 2: The steps (and sources/methods) involved in identifying behavior change 141 
techniques for inclusion in a complex intervention  142 
  143 
  144 
APEASE = Affordability, Practicability, Effectiveness, Acceptability, Side effects/ safety, Equity; BCT = Behavior 145 
Change Technique; QES = Qualitative Evidence Synthesis; TDF = Theoretical Domains Framework  146 
  147 
Overview of development of complex intervention  148 
We broadly followed the BCW approach [18] to intervention development as operationalized 149 
by Sinnott et al. [23]. These researchers conducted a qualitative evidence synthesis (QES) and 150 
semi-structured interviews in order to gain a deeper understanding of the behavior, prior to 151 
identifying BCTs through an expert panel consensus meeting. Sinnott et al. argued that the 152 
conduct of these qualitative studies generated much needed data on the research problem 153 
and was a strength of the approach undertaken [23].  154 
Intervention development began by conducting a QES exploring the complex influences on 155 
decision-making regarding antipsychotic prescribing to nursing home residents with dementia, 156 
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using meta-ethnography (Figure 2)[30]. One of our key findings was the need to target both 157 
the main requesters (i.e. nursing staff) and prescribers (i.e. GPs) of antipsychotics when 158 
designing any intervention.  A follow-on qualitative study using the Theoretical Domains 159 
Framework (TDF), an integrative framework of influences on behavior developed  by 160 
synthesizing multiple behavior change theories,  explored the determinants of appropriate 161 
requesting and prescribing behaviors across the 14 TDF domains [31]. From this study, the 162 
predominant TDF domains were identified, highlighting what needs to change for the desired 163 
behaviors to occur, and indicating some potential intervention options (Figure 2). The largely 164 
deductive approach used for the qualitative study complemented the inductive approach of 165 
the QES. The next step in developing an intervention was to identify appropriate BCTs and this 166 
leads us onto our current study.   167 
Current study  168 
The current study targeted the Irish nursing home setting, where most of the care is provided 169 
by on-site nurses and healthcare assistants, with regular visits from physicians (GPs and/or 170 
specialists) who are generally based off-site. We undertook a comprehensive approach to 171 
identifying all potential BCTs (‘long list’) from three sources (Figure 2) and then selected the 172 
most appropriate BCTs for our intervention using a Delphi consensus survey with a broad 173 
range of experts. The QES was not considered a source of BCTs due to its bottom-up, 174 
metaethnographic approach, but rather it informed the TDF-based qualitative interview study. 175 
Designing an intervention with the best possible potential for future implementation was a 176 
key part of the process, and we aimed to engage and catalyze dialogue between the 177 
researchers, practitioners and members of the public in identifying the intervention content.  178 
Therefore, as a core component of our intervention development process for the project, we 179 
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established PPI advisory groups, one with people with dementia, and one with family carers, 180 
with whom we consulted on an ongoing basis.   181 
The PPI advisory group meetings with people with dementia were co-facilitated by the primary 182 
author and a member of the Alzheimer Society of Ireland and used participatory approaches 183 
to support members to get involved, including flipcharts, coloured cards and assistance with 184 
writing. Four sessions occurred in total. The meetings with family members were less 185 
structured, and although three face-to-face group meetings took place, most of the 186 
interactions were via phone, email or letters. Alongside our PPI advisory groups, we separately 187 
consulted with professional stakeholders (three GPs, one consultant geriatrician, two 188 
consultant psychiatrists of old age, three nurses and two pharmacists) who were involved in 189 
providing care to nursing home residents with dementia. These consultations tended to be 190 
less structured than that of the PPI groups and occurred throughout the intervention 191 
development process. For example, these consultations took place in-person (as a small group 192 
or one-to-one), or else via phone or email. Ethics approval was provided by the local research 193 
ethics committee (ECM 4X 19/01/16).   194 
Generation of ‘Long List’ of BCTs  195 
Three sources were used to create a ‘long list’ of BCTs (Figure 2):  196 
Source 1: BCT intervention content of the 22 studies [32-54] included in a 2014 systematic 197 
review [10]. This systematic review examined interventions to reduce inappropriate 198 
prescribing of antipsychotics to nursing homes with dementia and was selected as we 199 
considered it to be the most comprehensive and highest quality review in this area. BCTs from 200 
each intervention study directed at our target behaviors (appropriate requesting and 201 
prescribing of antipsychotics) were coded by the primary author using the BCTTv1 [20]. The 202 
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primary author had completed online and face-to-face training in BCTTv1. All BCTs that were 203 
coded in at least two studies were added to the ‘long list’. This requirement of two prior uses 204 
aimed to minimize inclusion of erroneous one-off BCTs due to the often-suboptimal nature of 205 
intervention reporting, and to account for the inherent interpretive nature of BCT coding.  206 
Source 2: Mapping of predominant TDF domains to the BCTs [31]. The TDF consists of 14 207 
domains and provides a comprehensive, theory-informed approach to identifying the 208 
determinants which influence behaviors [55]. The TDF also aligns with the first stage of the 209 
BCW [18]. In our previous qualitative study with local healthcare providers and family carers, 210 
we used the TDF to identify what factors need to change in order to achieve the desired change 211 
in antipsychotic prescribing behaviors i.e. a ‘behavioral diagnosis’ was undertaken. For this 212 
qualitative study, the predominant TDF domains and determinants influencing these complex 213 
prescribing behaviors were identified [31]. Nine predominant TDF domains were identified: 214 
Behavioral regulation; Beliefs about capabilities; Beliefs about consequences; Emotion; 215 
Environmental context and resources; Knowledge; Memory, attention, and decision processes; 216 
Social influences; and Social/professional role and identity [31]. These TDF domains were then 217 
mapped to the relevant BCTs from the BCTTv1 guided by methods described by Cadogan et al. 218 
[56, 57].   219 
A mapping tool developed by Cane et al. [58] was used as the primary guiding document and 220 
provided clear links between 12 (of the 14) TDF domains and the BCTs from BCTTv1. Notable 221 
omissions are with regard to the Memory, attention and decision-processes and 222 
Social/professional role and identity TDF domains which are not mapped to any BCTs using this 223 
tool. This is because in the original mapping study by Cane et al., experts did not consistently 224 
allocate any BCT to these two domains [58].  To circumvent this problem, an older mapping 225 
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matrix developed by Michie et al. [59] was used to map these two TDF domains to the BCTs. 226 
This particular matrix [59] was developed prior to the establishment of the BCTTv1 [20], hence 227 
there are differences in terms of the BCT labels and definitions between these two matrices 228 
[58, 59]. However, there is also substantial overlap between these different versions of BCTs.  229 
Hence for the purpose of clarity, the few BCTs that were identified using the older matrix were 230 
converted to their nearest BCTTv1 equivalent.   231 
Source 3: Mapping of intervention functions to the BCTs. Intervention functions are defined 232 
as “broad categories of means by which an intervention can change behavior” [18]. The 233 
‘behavioral diagnosis’ from our qualitative study, [31] helped us to specify what exactly 234 
needed to change in order to bring about the desired behavior, and using BCW matrices we 235 
were able to identify the range of intervention functions most likely to be effective in achieving 236 
this change [18]. To help us select the most appropriate intervention functions, our research 237 
team (the five authors of this paper) used the APEASE criteria (affordability, practicability, 238 
effectiveness, acceptability, side effects and equity) to identify the functions relevant to this 239 
intervention. Sustainability issues were also discussed by the research team, for example, we 240 
considered whether the intervention sites could or would continue to engage with the 241 
proposed intervention functions after we had completed our research.  242 
 The primary author also used the APEASE criteria with a range of professional stakeholders, 243 
and in a less formal manner with the PPI advisory group members, for example asking, “What 244 
type of intervention would you like to see, and why?” Specifically, we intentionally did not go 245 
through the APEASE criteria systematically with PPI advisory group members, as we felt that 246 
the questions might be too academic for some members. Instead potential interventions 247 
options were described, and this would prompt a broader discussion between members. The 248 
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recordings from these sessions were used to inform the ongoing intervention development 249 
process at all stages. Points raised by the PPI advisory groups were discussed with the 250 
professional stakeholders at a later stage, and vice versa.   Using BCW guidance [18], we then 251 
mapped our selected intervention functions to the most frequently used BCTs for each 252 
relevant intervention function.   253 
At the end of this process, BCTs from all three sources were collated into a ‘long list’ alongside 254 
their definitions and operationalized examples within the context of antipsychotic prescribing 255 
to nursing home residents with dementia. Two of the research team members generated this 256 
list to ensure that all BCTs could be operationalized for the purpose of our intervention, and 257 
that the examples remained true to their respective BCT definition.  258 
Consensus-approach to identifying BCTs  259 
Using the approach reported by Millar et al. as a guide [60], we conducted an online tworound 260 
Delphi survey with a range of experts to reach consensus on the most appropriate BCTs for 261 
our planned intervention. This approach was selected due to the clear and transparent 262 
methods described for gaining consensus on interventions in a similar care setting (i.e. nursing 263 
homes).   264 
Notably, our Delphi survey was distinct from the PPI process, as the former sought to achieve 265 
a level of consensus specifically for identifying BCTs, whereas the latter sought to inform the 266 
intervention development process as a whole, via involvement and engagement, and occurred 267 
over a much longer period of time (Figure 2). Panellists were recruited, both internally from 268 
within PPI and stakeholder advisory groups and externally, based on meeting at least one of 269 
the following criteria:  270 
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• knowledge or experience of antipsychotic prescribing in 271 
dementia   272 
• expertise in behavior change or implementation science   273 
carer of a person with dementia.   274 
All panellists that agreed to participate were emailed a link to the survey and given a deadline 275 
of 3-4 weeks to complete each round, with a reminder email sent as necessary. Only the 276 
panellists who completed the first round were invited to the second round.  277 
From our previous research, we concluded that the intervention should target both the 278 
prescriber (GP) and requester (nurse), and this was outlined in the Delphi survey instructions 279 
(Figure 3) [30]. However, we did not explicitly anchor the panellists towards GPs or nurses, as 280 
we were open to broadening our targets based on the feedback from panellists. Furthermore, 281 
this feedback informed discussions with the research team to consider important system level 282 
barriers and facilitators, and whether different BCTs may be required for different intervention 283 
targets.   284 
Figure 3: Example screenshot from an item in the first round  285 
  286 
  287 
Each of the two rounds were sent to the panellists using an online survey tool 288 
(SurveyMonkey®, California, US). Panellists were asked to rate how important they perceived 289 
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each BCT with respect to its unique contribution to an intervention targeting appropriate 290 
antipsychotic requesting and prescribing, for nursing home residents with dementia. Panellists 291 
were provided with the BCT label, definition and an operationalized example.  292 
Panellists were instructed to score the importance of each BCT on a Likert scale ranging from 293 
1 (not important) to 9 (critically important). Panellists were also able to select ‘unable to score’ 294 
if they felt they could not offer any opinion on that particular BCT [61] (Figure 3). Panellists 295 
were also provided with room for additional comments after every BCT and were invited at 296 
the end of the first round to suggest additional BCTs which they considered to be important. 297 
These suggested BCTs were collated at the end of the first round and added into the second 298 
round.   299 
Consensus for a BCT being included in the intervention was defined as ≥ 70% of panellists 300 
scoring 7-9 and < 15% scoring 1-3. Exclusion was defined as ≥ 70% scoring 1-3 and < 15% 301 
scoring 7-9, in line with the methods described by Millar et al. [60]. This scoring system 302 
originated from the recommendations of the Grading of Recommendations Assessment, 303 
Development and Evaluation (GRADE) Working Group [61]. The second-round survey only 304 
contained BCTs for which no consensus had been reached, along with some additional new 305 
BCTs which had been suggested by panellists. Anonymized group scores from round-one were 306 
presented beside the BCTs, and panellists were asked to consider this feedback when 307 
rescoring. At the end of round-two, BCTs that still did not meet consensus were excluded. Data 308 
were analyzed descriptively using Microsoft Excel 2013 (WA, USA).   309 
Qualitative feedback provided by the panellists was analyzed thematically and informed the 310 
second round of the Delphi study. Following the consensus step, to ensure the selected BCTs 311 
were appropriate for the Irish context and feasible within the limited resources of the planned 312 
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intervention, the research team applied the APEASE criteria and considered sustainability 313 
issues, one last time, to determine the final set of BCTs.   314 
The qualitative feedback provided by the panellists, along with input from the PPI and 315 
stakeholder groups also informed the intervention development more broadly.  316 
Results  317 
Generation of ‘Long List’ of BCTs  318 
Source 1 (systematic review): Twenty-three unique BCTs were identified by coding the 319 
intervention content of the 22 studies included in the 2014 systematic review [10]. Of these  320 
23 BCTs, 18 were coded in at least two studies, and hence were added to the ‘long list’  321 
(Supplementary Table S.1). The three most prevalent BCTs among included studies were #4.1 322 
Instruction on how to perform a behavior in 15 studies [32, 34, 36-40, 42, 44, 46, 49-51, 53, 323 
54], #1.4 Action planning in 14 studies [32, 34-36, 40, 41, 44-48, 52-54] and #1.2 Problem 324 
solving in 13 studies [32, 36-39, 41, 44-46, 48, 50, 53, 54].  325 
Source 2 (qualitative study): Mapping of our nine predominant TDF domains (as identified 326 
from our qualitative study [31]) to the BCTs using the Cane matrix [58] resulted in the 327 
identification of 32 BCTs. The Michie matrix [59] identified four BCTs (Planning,  328 
Implementation; Self-monitoring; Social processes of encouragement, pressure, support; and 329 
Prompts, triggers, cues). These four BCTs were converted to their nearest BCTTv1 equivalents 330 
of #1.4 Action planning, #2.3 Self-monitoring of behavior, #3.1 Social support (unspecified) and 331 
#7.1 Prompts/cues respectively.  332 
Source 3 (mapping intervention functions to the BCTs): Linking our nine predominant TDF 333 
domains to BCW intervention functions [18], all nine intervention functions were determined 334 
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to be potentially relevant. Using the APEASE criteria among our research group, with PPI and 335 
stakeholder input and considering sustainability issues, we included the following five 336 
intervention functions; Education, Persuasion, Training, Environmental restructuring and 337 
Modelling (Supplementary Table S.2). When asked, our PPI advisory group felt strongly that 338 
education was key to changing behaviors, and hence should be a central part of any 339 
intervention. Using BCW guidance [18], we mapped these five selected intervention functions 340 
to the most frequently used BCTs for each respective intervention function,  thereby 341 
identifying 12 BCTs.  342 
In total, 42 unique BCTs across 15 BCT clusters were identified from the three different sources 343 
and were included in our ‘long list’, after removal of 24 duplicate BCTs (Supplementary Table 344 
S.3). Initial screening of these 42 BCTs resulted in one BCT being removed (#2.6 Biofeedback), 345 
as it was agreed that this BCT was inoperable within the context of any possible intervention. 346 
Hence 41 BCTs were included in our finalized ‘long list’ and were operationalized with 347 
examples for the purpose of the Delphi survey (Supplementary Table  348 
S.4).   349 
Consensus-approach to identifying BCTs  350 
A broad range of stakeholders (n=19) from three countries (Ireland, United Kingdom and 351 
Canada) were invited to participate in the Delphi survey; 18 agreed to participate and 16 352 
completed both rounds. The 18 panellists included implementation scientists or behavior 353 
change experts (n=3), GPs (n=3), nurses (n=3), pharmacists (n=3), consultant psychiatrists of 354 
old age (n=2), psychologists with health services research expertise (n=2), a consultant 355 
geriatrician (n=1), and a carer (n=1). The carer and one nurse did not complete the second 356 
round. Panellists were advised that the examples provided were not necessarily indicative of 357 
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any planned intervention, nor were we necessarily advocating them. Rather the examples 358 
served the purpose of understanding the meaning of these BCTs in the context of a 359 
hypothetical intervention.  360 
At the end of the first round of the Delphi study, 12 of the 41 BCTs met the inclusion criteria 361 
and none met the exclusion criteria. Five new BCTs were included in round 2 based on 362 
panellists’ suggestions (#1.5 Review behavior goal(s), #1.6 Discrepancy between current 363 
behavior and goal, #8.3 Habit formation, #13.2 Framing/re-framing and #13.3 Incompatible 364 
beliefs). These were added to the 29 BCTs for which consensus was not reached.   365 
BCTs that focused on positive attitudes and working together as a team, such as #1.2 Problem 366 
solving, #1.4 Action planning, #12.2 Restructuring the social environment and #13.1 367 
Identification of self as role model were viewed favorably by panellists. Regarding BCT #12.2, 368 
one panellist commented:  369 
“An important point as the social influence on prescribing is likely to be significant and 370 
change will require that all involved are in agreement with a resident’s care plan.”  371 
Conversely BCTs that had negative connotations such as #5.5. Anticipated regret and #16.1 372 
Imaginary punishment, were considered highly inappropriate, unacceptable and potentially 373 
unethical:  374 
“This form of punishment will likely not be acceptable in the health system.”  375 
Hence 34 BCTs were circulated in round-two, of which 10 then met the inclusion criteria and 376 
two met the exclusion criteria. Therefore, at the end of both rounds, 22 BCTs met the inclusion 377 
criteria and two BCTs met the exclusion criteria (Table 1).   378 













scoring  7-9  
‘critically  
important’ (%)  
Respondents  




1.1 Goal setting (behavior)†  6.64  7  78.6  14.3  
1.2 Problem Solving†  8.56  9  93.75  0  
1.4 Action Planning†  8.19  9  93.75  0  
1.5 Review behavior goal(s)  7.14  7  85.7  0  
1.6 Discrepancy between current 
behavior and goal  
7.36  7  78.6  0  
2.2 Feedback on behavior†  7  7  81.25  6.25  
4.1 Instruction on how to perform a 
behavior†  
7.29  7.5  78.58  7.14  
4.2 Information about 
antecedents†  
7.27  7  73.33  0  
5.1 Information about health 
consequences  
7.64  9  78.6  7.1  
6.1 Demonstration of the 
behavior†  
7.64  8  78.6  7.1  
6.2 Social Comparisons†  7.46  8  76.9  0  
7.1 Prompts/cues†  7.5  7  78.6  0  
8.1 Behavioral practice/rehearsal  7.29  8  71.4  0  
8.2 Behavior Substitution†  7.8  8  86.7  0  
8.3  Habit formation  7.5  8  85.7  0  
9.1 Credible Source†  7.47  8  73.3  0  
12.1 Restructuring the physical 
environment  
7.21  7.5  78.6  7.1  
12.2 Restructuring the social 
environment  
7.14  7  78.6  0  
12.5 Adding objects to the 
environment†  
7.73  8  86.7  0  
13.1 Identification of self as a role  
model  
6.93  7  71.4  0  
13.2 Framing/re-framing  6.86  7  71.4  14.3  
15.3 Focus on past success  7.29  7.5  71.4  0  
Excluded 








scoring  7-9  
‘critically  
important’ (%)  
Respondents  




12.3 Avoidance/reducing exposure 
to cues for the behavior  
2.21  1  7.1  78.6  
16.1  
Imaginary punishment  
2.5  2  7.1  71.4  
21  
  
378 BCTs = Behavior Change Techniques; † = Met inclusion criteria in the first round.  
 
Applying the APEASE criteria as a research team to these 22 BCTs and considering 380 sustainability 
issues, resulted in a finalized list of 16 BCTs from 10 BCT clusters (Table 2).   
381  Table 2: Use of APEASE criteria to finalize behavior change techniques  
382    
 







Reasons for exclusion  
  
  
1.1  Goal setting 
(behavior)  
            No  Feedback from panellists was 
generally skeptical. National or 
regional data on antipsychotic 
prescribing patterns in nursing home 
residents with dementia is not 
readily available in Ireland, hence 
this BCT is not practicable. 
Furthermore, there may be some 
safety concerns about 
indiscriminately reducing 
antipsychotic prescribing levels.  
1.2  Problem Solving              Yes     
1.4  Action Planning              Yes    
1.5  Review behavior 
goal(s)  
            No  As 1.1  
1.6  Discrepancy 
between current 
behavior and goal  
            No  As 1.1  
2.2  Feedback on 
behavior  
            No  As 1.1  
4.1  Instruction on 
how to perform a 
behavior  
            Yes    
4.2  Information 
about 
antecedents  
            Yes    
5.1  Information 
about health 
consequences  
            Yes    
6.1  Demonstration of 
the behavior  
            Yes    
22  
  
6.2  Social  
Comparisons  
            No  As 1.1  
  
In addition, feedback suggested that 
comparator data needs to be 
matched for each individual 
prescriber in order to be useful  
(which is not feasible)  
7.1  Prompts/cues              Yes    
8.1  Behavioral 
practice/ 
rehearsal  
            Yes    
8.2  Behavior  
Substitution  
            Yes    
8.3   Habit formation              Yes    
9.1  Credible Source              Yes    
12.1  Restructuring the 
physical 
environment  
            No  Restructuring the physical 
environment for the purpose of this 
time and budget-constrained 
intervention, would not be 
affordable or practicable.  
12.2  Restructuring the  
social  
environment  
            Yes    
12.5  Adding objects to 
the environment  
            Yes    
23  
  
13.1  Identification of  
self as a role 
model  
            Yes    
13.2  Framing/reframing              Yes    
15.3  Focus on past 
success  
            Yes    
BCT = Behavior Change Technique  
  0 
 Qualitative feedback from the panellists influenced our decision-making. Generally, feedback 1 
towards all goal setting BCTs was met with skepticism. Specifically, in relation to the BCT #1.1 2 
Goal setting (behavior), some panellists felt that setting targets for antipsychotic prescribing 3 
reductions may not have the intended consequence:   4 
“This is not helpful - prescribing needs to be appropriate, not necessarily reduced. You 5 
might have no reduction, after a goal of 10% reduction, and staff would become 6 
demoralized, even though a good process (exists).”   7 
Although the BCT #6.2 Social comparison was rated relatively highly in terms of importance 8 
for changing prescribing behaviors (Table 1), several panellists expressed concerns that unless 9 
the prescribing data were matched to each physician’s local patient population, then 10 
comparing their prescribing to that of their peers was not necessarily beneficial. Currently, 11 
there are no such systems in place at a regional or national level in Ireland to allow prescribers 12 
to compare their antipsychotic prescribing practices to their peers. Moreover, there were 13 
some concerns that the prescribers may be potentially identifiable from any de-novo local 14 
dataset, and hence there was some reluctance to engage in audit and feedback:  15 
“Importance depends on comparator selected: physicians may be more likely to 16 
identify with local comparators than national (although may be feasibility issues with 17 
local comparators).”  18 
24  
  
Therefore, goal setting and social comparison BCTs were judged to have acceptability, 19 
practicability and safety issues according to the APEASE criteria,  and were excluded by the 20 
research team (Table 2). The reasons for exclusion of all six BCTs at this stage are outlined in 21 
Table 2.  22 
Discussion  23 
This paper describes the process of identifying BCTs for inclusion in a complex intervention 24 
aimed at sustainably reducing inappropriate antipsychotic prescribing to nursing home 25 
residents with dementia. By using the BCW approach, and detailing our process, we have 26 
identified BCTs in a transparent manner and have thus enabled replication of our process by 27 
other researchers. Hence, the method described here to identify appropriate BCTs could be 28 
used as an example for other interventions. Our findings also have implications for practice, 29 
as the BCTs identified may be used as the basis for behavior change and quality improvement 30 
interventions by GPs and nurses working in the nursing home setting.  31 
A systematic review and meta-analysis of BCTs in deprescribing interventions across contexts 32 
was published in 2018 by Hansen et al. [62]. Of 1,561 articles identified by the authors, 25 33 
studies were included in this review, identifying 28 BCTs and 13 BCT clusters targeting 34 
deprescribing behaviors. The most frequently coded BCTs among included studies were #4.1 35 
Instruction on how to perform a behavior (n=16), #9.1 Credible source (n=16) and #2.2 36 
Feedback on behavior (n=14). There was a large overlap between the BCTs we identified 37 
through coding the systematic review by Thompson-Coon et al. (n=18 BCTs) [10] and those 38 
identified in the systematic review by Hansen et al. (n=28 BCTs) [62], despite the lack of 39 
overlapping studies between the two systematic reviews. For example, of the 10 BCTs 40 
identified by Hansen et al. and not initially identified by us, five of these were later identified 41 
25  
  
through other sources of BCTs. The five remaining BCTs that were not identified by us through 42 
this process were unlikely to be included in the final intervention for various reasons. For 43 
example, panellists’ responses suggested that some BCTs from the goals and planning, 44 
feedback and monitoring or comparison of behavior clusters would not be feasible in an Irish 45 
nursing home setting, due to the lack of routine feedback on antipsychotic prescribing 46 
practices. However, due to evidence to support the effectiveness of audit and feedback 47 
strategies [63], policymakers should consider developing suitable systems to enable 48 
prescribers to compare their own antipsychotic prescribing levels to that of their peers, in a 49 
meaningful manner.  50 
Although previous studies have used Delphi surveys to  identify BCTs for inclusion in behavior 51 
change interventions [26, 28, 29], key questions remain with regards to how best to select 52 
the most appropriate BCTs for a planned intervention. A standardized approach to selecting 53 
BCTs (such as the one undertaken in the current study) should be developed and agreed upon, 54 
to provide guidance for intervention developers and researchers. Additionally, more research 55 
is required to determine the most efficient approach to identifying and testing which BCTs 56 
lead to sustainable behavior change and ultimately better patient outcomes. One of the key 57 
strengths of this study was the transparent use of innovative methods to identify BCTs. By 58 
using this systematic and transparent approach we believe that we have contributed to the 59 
evolving science of complex intervention development. By retrieving potential BCTs from 60 
three different sources informed by previous research [10, 30, 31], and by involving a wide 61 
range of individuals in this process, we believe that we have used a comprehensive approach 62 
to identify the most appropriate BCTs for our planned intervention. Of particular benefit to 63 
further developing our intervention was the elicitation of stakeholders’ views on certain BCTs, 64 
26  
  
through the Delphi survey, PPI and stakeholder advisory groups. These views have helped to 65 
contextualize some of the key issues relevant to the Irish nursing home setting and have 66 
reinforced the importance of education and teamwork.   67 
We argue that the precise qualitative methodologies adopted by intervention developers 68 
should suit the research questions rather than follow any strict protocol. For example, we 69 
used a deductive, TDF-based approach for our interview study [31]. Whereas Sinnott et al. 70 
(who also used the BCW [23]) used an inductive, grounded theory approach for their 71 
interview study [64]. Both approaches informed our respective intervention development 72 
processes, thereby indicating that either approach may be appropriate depending on the 73 
research questions asked.  74 
One of the limitations of our study was the constrained involvement of people with dementia 75 
and carers in our Delphi survey. The carer who attempted the Delphi survey (along with some 76 
of the participating healthcare professionals) found the language of BCTs excessively 77 
academic. We had considered involving more PPI advisory group members in the Delphi 78 
survey; however, it is likely that the same situation would have arisen and may have resulted 79 
in undue stress in those individuals. In hindsight, their involvement in this particularly 80 
academic BCT identification process may not have been appropriate.  Although we held 81 
several participatory meetings with PPI advisory group members, even more face-to-face time 82 
describing the possible intervention options and using participatory techniques such as card 83 
sorting and direct ranking may have been a more appropriate method of co-creating an 84 
intervention [65]. Alternatively, the approach used by Fergie et al. may have been more 85 
accommodating as it enables panellists to rank the importance of various options and to 86 
discuss potential solutions, in plain English, and only after consensus is reached are the 87 
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findings coded by the researchers using BCTs [29]. However, time constraints prevented us 88 
from attempting these alternative approaches. Though we may have unsuccessfully involved 89 
PPI advisory group members in commenting on the precise components of a provider-facing 90 
intervention, the members created a rich narrative around their values and preferences that 91 
will be crucial in implementing the complex intervention. The challenge of meaningfully 92 
involving patients and public in research is an important issue to address as there are unique 93 
insights and mutual benefits that can only be gained by truly involving people directly affected 94 
by a condition [15, 66]. More evidence is required to help researchers understand how best 95 
to meaningfully involve people with dementia and carers in the development of 96 
theoryinformed interventions.  97 
The next step in our project involves identifying the mode of delivery for our intervention, in 98 
addition to the sequencing and packaging of our selected intervention functions and BCTs. 99 
Inappropriate antipsychotic prescribing to nursing home residents with dementia has become 100 
a topical subject in recent times due to increased media scrutiny [67]. Many different 101 
interventions and strategies have been developed recently in an attempt to curb this 102 
inappropriate prescribing, both at local and national levels, including a repeat prescribing tool 103 
for GPs [68], a program combining staff training, social interaction, and antipsychotic 104 
prescribing guidance [69] and public reporting of antipsychotic prescribing levels in nursing 105 
homes [70].   106 
While the focus of the current research was at the behavioral level, the successful 107 
implementation of the intervention will also require a consideration of the systems level and 108 
wider context. The issue of appropriate prescribing could also benefit from drawing more 109 
broadly from the implementation science literature, for example exploring the issue as an 110 
28  
  
example of the ‘de-implementation’ of harmful practice [71].  From our previous qualitative 111 
research [30, 31], it was evident that multifaceted approaches are needed in order to achieve 112 
sustainable improvements. It is therefore important to consider the full range of potential 113 
modes of delivering our intervention, including the suitability of various theoretical 114 
approaches used in implementation science, before deciding on the most appropriate for our 115 
particular target behaviors, population groups and setting [18]. For example, though we have 116 
identified education should be a core component of our intervention, we need to determine 117 
how best to deliver educational interventions, using which theory, and alongside what, to 118 
achieve sustainable results.   119 
Conclusion  120 
Sixteen BCTs were identified for inclusion in a complex intervention targeting GP and nursing 121 
antipsychotic prescribing and requesting behaviors to nursing home residents with dementia, 122 
through an expert consensus process. More research is required to help researchers 123 
understand how best to meaningfully involve people with dementia and carers in the 124 
development of a theory-informed intervention, and how best to select BCTs for complex 125 
interventions. The systematic and detailed approach undertaken to identify appropriate BCTs 126 
in this study, could be used as an example for other interventions.  127 
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Supplementary Material 
Table S.1: Behavior Change Techniques identified in the 22 interventional studies included in the systematic review by Thompson-Coon et al.  




                                              
Schultz 
(1991)  
                                              
Avorn 
(1992)  
                                              
Rovner 
(1992)  
                                              
Ray  
(1993)  
                                              
Meador 
(1997)  
                                              
Heal 
(1998)  
                                              
Schmidt 
(1998)  
                                              
Earthy 
(2000)  
                                              
Ballard 
(2002)  
                                              
Hagen 
(2005)  




                                              
Study  1.1  1.2  1.3  
(year)  
1.4  2.2  2.3  2.4  3.1  3.2  3.3  4.1  4.2  5.1  5.3  6.1  6.2  7.1  8.1  8.2  9.1  12.1  12.2  12.5  
Dahl 
(2008)  
                                              
Monette 
(2008)  
                                              
Morrisso 
n (2009)  
                                              
Patterso 
n (2010)  
                                              
Westbur 
y (2010)   
                                              
Testad 
(2010)  
                                              
Khan 
(2011)  




                                              
Vida 
(2012)  
                                              
Monette 
(2013)  
                                              
Total no. 
of BCTs  
6  13  4  14  8  4  1  2  8  1  15  4  11  11  5  1  7  1  3  12  1  11  3  
1.1 = Goal setting (behavior);  1.2 = Problem solving;   1.3 = Goal setting (outcome); 1.4 = Action planning; 2.2 = Feedback on behavior;  2.3 = Self-
monitoring of behavior; 2.4 = Self-monitoring of outcome(s) of behavior; 3.1 = Social support (unspecified); 3.2 = Social support (practical); 3.3 = Social support (emotional); 
4.1 =  
 
Instruction on how to perform the behavior; 4.2 = Information about antecedents; 5.1 = Information about health consequences;  5.3 = Information about social and 
environmental consequences; 6.1 = Demonstration of the behavior; 6.2 = Social comparison; 7.1 = Prompts/cues; 8.1 = Behavioral practice/rehearsal; 8.2 = Behavior 
substitution; 9.1 = Credible source; 12.1 = Restructuring the physical environment; 12.2 = Restructuring the social environment; 12.5 = Adding objects to the environment 
 
























            No  Creating an expectation of punishment or cost 
was not acceptable to any stakeholder. There 
were also concerns regarding the practicability 
of implementing such an intervention and also 
regarding the potential safety issues regarding 
not prescribing antipsychotics.  
Education  
(increasing 
knowledge or  
understanding)  
  










            No  Increasing means/reducing barriers to increase 
capability or opportunity was acceptable to all 
stakeholders. However operationalization of 
this intervention function (e.g. information 
technologies) was not seen to be practicable 
for this intervention.  




physical or  
social context)  
  
            Yes    
Incentivization 
(Creating an 
expectation of  
reward)  
  
            No  Utilizing an incentivization function was not 
judged to be affordable due to budgetary 
constraints. Some stakeholders also believed 
that it was not ethical to incentivize GPs/nurses 
to conduct a behavior that they should be 
doing anyway, hence it was not acceptable by 
those in management.  





aspire to or  
imitate)  
  





to induce  







        
Restriction 
(Using rules to 
reduce the 
opportunity to 




            No  Restriction was not acceptable to any 
stakeholder as it would ‘limit agency on the part 
of the target group’. There were also concerns 
regarding the practicability of implementing 
such an intervention and also regarding the 
potential safety issues regarding not 





            Yes    
BCW = Behavior Change Wheel; APEASE = Affordability, Practicability, Effectiveness, Acceptability, Side effects/ 
safety, Equity  
   
 
Table S.3: The ‘Long List’ of BCTs and source(s)  






2(a). TDF domains 
via Cane matrix 
(qualitative study)  
2(b). TDF domains 
via Michie matrix 
(qualitative study)  
3. Intervention 
Functions: BCW 
guidance (APEASE  
criteria)  
1.1 Goal setting (behavior)          
1.2 Problem solving          
1.3 Goal setting (outcome)          
1.4 Action planning          
2.2 Feedback on behavior          
2.3 Self-monitoring of 
behavior  
        
2.6 Biofeedback          
2.7 Feedback on 
outcome(s) of behavior  
        
3.1 Social support  
(unspecified)  
        
3.2 Social support  
(practical)  
        
3.3 Social support  
(emotional)  
        
4.1 Instruction on how to 
perform a behavior  
        
4.2 Information about 
antecedents  
        
5.1 Information about 
health consequences  
        
5.2 Salience of 
consequences  
        
5.3 Information about 
social and environmental 
consequences  
        
5.4 Monitoring of 
emotional consequences  
        
5.5 Anticipated regret          
5.6 Information about 
emotional consequences  
        
6.1 Demonstration of the 
behavior  
        
6.2 Social comparison          
6.3 Information about 
others’ approval  
        
7.1 Prompts/cues          
7.2 Cue signalling reward          
 
8.1 Behavioral practice/ 
rehearsal  
        
8.2 Behavior substitution          
9.1 Credible source          
9.2 Pros and cons          
9.3 Comparative imagining 
of future outcomes  
        
10.4 Social reward          
10.11 Future punishment          
11.2 Reduce negative 
emotions  
        
12.1 Restructuring the 
physical environment  
        
12.2 Restructuring the 
social environment  
        
12.3 Avoidance/reducing 
exposure to cues for the 
behavior  
        
12.5 Adding objects to the 
environment  
        
13.1 Identification of self as 
role model  
        
15.1 Verbal persuasion 
about capability  
        
15.3 Focus on past success          
16.1 Imaginary punishment          
16.2 Imaginary reward          
16.3 Vicarious 
consequences  
        
Total number of BCTs 
identified*  
18  32  4  12  
  





















Table S4: Operationalized BCT examples for the purpose of online Delphi study  
Label  BCT Definition  Operationalised Example  
1.1 Goal setting  
(behavior)  
Set or agree on a goal defined in terms of the behavior to be achieved  
  
  
Nursing home staff/GPs set a goal to reduce the total number of 
residents who are prescribed an antipsychotic over 3 months  
  
1.2 Problem Solving  Analyze, or prompt the person to analzse, factors influencing the 
behavior and generate or select strategies that include overcoming 
barriers and/or increasing facilitators  
  
Identify factors (e.g. behavioral symptoms in residents) that may 
lead to an inappropriate request for an antipsychotic, and 
develop non-drug strategies to use in these situations  
  
1.3 Goal setting  
(outcome)  
Set or agree on a goal defined in terms of a positive outcome of 
wanted behavior  
  
Nursing home staff/GPs set a goal to reduce the number of falls in 
residents, as a result of reduced antipsychotic usage  
  
1.4 Action Planning  Prompt detailed planning of performance of the behavior (must 
include at least one of context, frequency, duration and intensity).  
  
Encourage nursing home staff to develop a plan of how and when 
non-drug intervention will be attempted first-line  
2.2 Feedback on behavior  Monitor and provide informative or evaluative feedback on 
performance of the behavior    
  
Inform nursing home staff/GPs of how many residents with 
dementia, under their care, are prescribed antipsychotics 
monthly  
  
2.3 Self-monitoring of 
behavior  
Establish a method for the person to monitor and record their 
behavior(s) as part of a behavior change strategy  
  
Ask nursing home staff to document every time they request an 
antipsychotic medication for a resident  
  
2.7 Feedback on outcome 
of behavior  
Monitor and provide feedback on the outcome of performance of the 
behavior  
  
Inform GPs of how many residents with dementia under their 
care who are prescribed antipsychotics, had a fall, monthly  
  
3.1 Social Support 
(unspecified)  
Advise on, arrange or provide social support (e.g. from friends, 
relatives, colleagues,’ buddies’ or staff) or non-contingent praise or 
reward for performance of the behavior. It includes encouragement  
and counselling, but only when it is directed at the behavior  
Ask GPs to reinforce/praise nursing staff for  completing the 
assessment tool, before requesting an antipsychotic  
 
3.2 Social Support  
(practical)  
Advise on, arrange, or provide practical help (e.g. from friends, 
relatives, colleagues, ‘buddies’ or staff) for performance of the 
behavior   
Advise nursing home staff to identify a colleague who  they can 
seek help from when completing an assessment tool for residents 
with behavioral symptoms  
 
 Label  BCT Definition  Operationalised Example  
3.3 Social Support  
(emotional)  
Advise on, arrange, or provide emotional social support (e.g. from 
friends, relatives, colleagues, ‘buddies’ or staff) for performance of 
the behavior  
  
Advise nursing home staff to identify a colleague who  they can 
seek emotional support from if a particularly distressing behavior 
occurs/reoccurs as a result of not requesting or prescribing an 
antipsychotic  
4.1 Instruction on how to 
perform a behavior  
Advise or agree on how to perform the behavior (includes ‘Skills 
training’)  
Provide written information to GPs on how to deprescribe an 
antipsychotic, in the form of an algorithm  
4.2 Information about 
antecedents  
Provide information about antecedents  
(e.g. social and environmental situations and events, emotions, 
cognitions) that reliably predict performance of the behavior  
Advise nursing staff to record on the assessment tool, details of 
situations or events that occurred leading to antipsychotic 
prescriptions   
5.1 Information about 
health consequences  
Provide information (e.g. written, verbal, visual) about health 
consequences of performing the behavior  
Provide written and oral information to GPs and Nursing home 
staff regarding the side effects of antipsychotics  
5.2 Salience of 
consequences  
Use methods specifically designed to emphasize the consequences of 
performing the behavior with the aim of making them more 
memorable (goes beyond informing about consequences)  
Provide nursing home staff with a sensationalized newspaper 
headline depicting the negative consequences of antipsychotic 
prescribing in residents with dementia  
  
5.3 Information about the 
social and environmental 
consequences  
Provide information (e.g. written, verbal, visual) about social and 
environmental consequences of performing the behavior  
Note: consequences can be for any target, not just the recipient(s) of 
the intervention;  
Provide written information to GPs and Nursing home staff 
regarding the costs of antipsychotics  
5.4 Monitoring of 
emotional consequences  
Prompt assessment of feelings after  attempts at performing the 
behavior  
  
Advise nursing home staff to record how they feel after  
requesting (or not requesting) an antipsychotic for a resident with 
behavioral symptoms  
5.5 Anticipated Regret  Induce or raise awareness of expectations of future regret about 
performance of the unwanted behavior  
Ask nursing staff/GPs to assess the degree of regret they will feel 
if they request/prescribe antipsychotics inappropriately  
 
5.6 Information about 
emotional consequences  
Provide information (e.g. written, verbal, visual) about emotional 
consequences of performing the behavior  
Provide visual information on the positive emotions experienced 
by nursing home staff when non-pharmacological interventions 
were used successfully  
  
6.1 Demonstration of the 
behavior  
Provide an observable sample of the performance of the behavior, 
directly in person or indirectly e.g. via film, pictures, for the person to 
aspire to or imitate  
Demonstrate to nursing staff how to use the assessment form 
using a pre-recorded video  
6.2 Social Comparison  Draw attention to others’ performance to allow comparison with the 
person’s own performance  
Show the GPs the proportion of nursing home residents with 
dementia nationally who were prescribed antipsychotics, and 
compare with their own data  
 
 Label  BCT Definition  Operationalised Example  
6.3 Information about 
others’ approval  
Provide information about what other people think about the 
behavior. The information clarifies whether others will like, approve or 
disapprove of what the person is doing or will do  
Tell the Nursing home staff that people with dementia and family 
carers strongly disapprove of the use of antipsychotics, except in 
certain situations  
7.1 Prompts/cues  Introduce or define environmental or social stimulus with the purpose 
of prompting or cueing the behavior. The prompt or cue would 
normally occur at the time or place of performance  
Place an assessment tool in the residents care plan as a reminder 
to complete, every time the resident exhibits behavioral 
symptoms  
7.2 Cue signalling reward  Identify an environmental stimulus that reliably predicts that reward 
will follow the behavior  
Advise nursing home staff that they will be rewarded for 
completing the assessment tool for residents with dementia, but 
will receive no reward for completing the tool in residents without 
dementia   
8.1 Behavioral 
practice/rehearsal  
Prompt practice or rehearsal of the performance of the behavior one 
or more times in a context or at a time when the performance may not 
be necessary, in order to increase habit and skill  
Prompt nursing home staff to practice using the assessment tool 
based on a case study in a classroom setting  
8.2 Behavior substitution  Prompt substitution of the unwanted behavior with a wanted or 
neutral behavior  
  
Prompt nursing home staff to suggest non-drug alternatives 
instead of prescribing antipsychotics  
9.1 Credible Source  Present verbal or visual communication from a credible source in 
favour of or against the behavior  
Delivery of an educational session on appropriate antipsychotic 
prescribing from a pharmacist who is an expert in this area   
 
9.2 Pros and Cons  Advise the person to identify and compare reasons for wanting (pros) 
and not wanting to (cons) change the behavior   
Ask nursing home staff to list and compare the    
advantages and disadvantages of antipsychotic prescribing in 
people with dementia  
9.3 Comparative  
imagining of future 
outcomes  
Prompt or advise the imagining and comparing of future outcomes of 
changed versus unchanged behavior  
Prompt GPs to imagine and compare likely or possible outcomes 
in the future, should current levels of inappropriate antipsychotic 
prescribing continue versus reduced levels of inappropriate 
prescribing  
10.4 Social Reward  Arrange verbal or non-verbal reward if and only if there has been 
effort and/or progress in performing the behavior  
Congratulate nursing home staff every time they complete the 
assessment tool   
10.11 Future punishment  Inform that future punishment or removal of reward will be a 
consequence of performance of an unwanted behavior (may include 
fear arousal) (includes ‘Threat’)  
Inform nursing staff/GPs that inappropriate  
requesting/prescribing of antipsychotics may result in public 
shaming/censuring by HIQA and/or the media  
11.2 Reduce negative 
emotions  
Advise on ways of reducing negative emotions to facilitate 
performance of the behavior (includes ‘Stress Management’)  
Advise nursing home staff on the use of stress management skills 
to reduce anxiety associated with not using antipsychotics in 
residents  
Label  BCT Definition  Operationalised Example  
12.1 Restructuring the 
physical environment  
Change, or advise to change the physical environment in order to 
facilitate performance of the wanted behavior or create barriers to 
the unwanted behavior (other than prompts/cues, rewards and 
punishments)  
Advise to paint the doors of the wards to prevent 
wandering/exitseeking behaviors in residents and hence reduce 
the need for antipsychotics  
12.2 Restructuring the 
social environment  
Change, or advise to change the social environment in order to 
facilitate performance of the wanted behavior or create barriers to 
the unwanted behavior (other than prompts/cues, rewards and 
punishments)  
Advise nurses to complete the assessment tool in conjunction 
with healthcare assistants, family members, GPs and residents 
(where appropriate)  
12.3 Avoiding/reducing 
exposure to cues for the 
behavior  
Advise on how to avoid exposure to specific social and  
contextual/physical cues for the behavior, including changing daily or 
weekly routines  
  
Advise GPs to limit ward rounds to once weekly to reduce face-
toface time with nursing home staff, and hence restrict the 
amount of inappropriate requests for antipsychotics  
12.5 Adding objects to the 
environment  
Add objects to the environment in order to facilitate performance of 
the behavior  
Provide assessment tools to the wards to enable appropriate 
requesting of antipsychotics  
 
13.1 Identification of self 
as role model  
Inform that one's own behavior may be an example to others  Inform nursing home staff that if they complete the assessment 
tool every time a resident exhibits a behavior, this may encourage 
other staff to start using the tool  
15.1 Verbal persuasion 
about capability  
Tell the person that they can successfully perform the wanted 
behavior, arguing against self-doubts and asserting that they can and 
will succeed  
Tell the GP that they can successfully improve the  
appropriateness of their antipsychotic prescribing despite the 
challenges that exist  
15.3 Focus on past 
success  
Advise to think about or list previous successes in performing the 
behavior (or parts of it)  
Advise the nursing home staff to describe occasions where 
nondrug strategies worked and antipsychotics were not needed  
16.1 Imaginary 
punishment  
Advise to imagine performing the unwanted behavior in a real-life 
situation followed by imagining an unpleasant consequence (includes 
‘Covert sensitisation’)  
Advise nursing home staff/GP to imagine inappropriate 
requesting/prescribing of antipsychotics followed by pubic 
shaming and censuring by the media and HIQA  
16.2 Imaginary reward  Advise to imagine performing the wanted behavior in a real-life 
situation followed by imagining a pleasant consequence (includes 
‘Covert conditioning’)  
  
Advise nursing home staff/GP to imagine not prescribing 
antipsychotics followed by an improvement in residents 
behavioral symptoms and their quality of life  
16.3 Vicarious 
consequences  
Prompt observation of the consequences (including rewards and 
punishments) for others when they perform the  behavior  
Draw attention to the negative media attention other GPs have 
received for prescribing antipsychotics inappropriately  
  
  
  
  
